Global COVID-19 Antigen Test Market to reach USD 8.35 Billion by 2027.Global COVID-19 Antigen Test Market is valued approximately at USD 5.3 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2021-2027. COVID-19 Antigen Tests have been gaining popularity as they are patient-friendly, easy to use, and have short test-to result timeline. The global COVID-19 Antigen Test market is being driven by the emergence of new deadly COVID-19 variants worldwide. For instance, according to the UK Health Ministry, in July 2021, 'Lambda', new COVID-19 strain has been detected in more than 30 countries. The other driving factor for the market growth is the increasing introduction of new antigen test kits by the private companies. For instance, in May 2021, MyLab Discovery Solutions, Indian company launched CoviSelf, the India's first self-use Covid-19 Rapid Antigen Test Kit available in the pharmacies across India. Furthermore, the growing concern among the people related to spread and influence of emerging variants, increasing cost of Covid-19 tests in the hospitals along with delay in results, possibility of catching infection in the long standing queue in the hospitals and increasing number of companies entering in the market will provide new opportunities for the global COVID-19 Antigen Test industry. However, unstable regulatory procedures for the approval may impede market growth over the forecast period of 2021-2027.

The global COVID-19 Antigen Test Market is segmented on the basis of regional analysis considering the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is the leading region across the world in terms of market share and is anticipated to exhibit the highest CAGR over the forecast period 2021-2027 due to growing infection among the large population, emergence of new startups and favorable government regulations.

Major market player included in this report are:
Abbott
SD Biosensor Inc.
Mylab Discovery Solutions Pvt. Ltd
GenBody Inc.
F. Hoffmann-La Roche AG
Access Bio., Inc.
ADS biotech Inc.
PerkinElmer, Inc.
Princeton BioMeditech Corporation
Becton, Dickinson and Company


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Service:
Platforms
Reagents & Kits
Services
By End-Use:
Clinics & Hospitals
Home Care
Diagnostic Labs
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global COVID-19 Antigen Test Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors